Journal: Scientific Reports
Article Title: Bone mesenchymal stem cells-derived exosomal miR-509-5p promotes osteogenic differentiation by targeting SFRP1 and activating the Wnt/β-catenin pathway
doi: 10.1038/s41598-025-33075-7
Figure Lengend Snippet: Inhibition of BMSCs-derived exosomal miR-509-5p impaired osteogenic differentiation via suppression of the Wnt/β-catenin pathway in hFOB1.19 cells. ( A ) miRNA qPCR array-based detection of differentially expressed miRNAs between the BMSCs-PBS and the BMSCs-derived exosomes group; ( B ) The expression of miR-15b-5p, miR-24-3p, miR-148a-3p, miR-181b-5p, and miR-509-5p in BMSCs-PBS and the BMSCs-derived exosomes group were detected by RT-qPCR; ( C ) RT-qPCR was performed to assess the mRNA level of miR-15b-5p after miR-15b-5p inhibition; ( D ) ALP staining was performed to assess osteogenic differentiation in each group; ( E ) Alizarin red S staining was performed to detect the mineralized area in each group; ( F-G ) Relative mRNA and protein levels of RUNX2, OCN, OPN, Osterix, and ALP in each group were analyzed by RT-qPCR and Western blot; ( H ) Western blot was performed to detect the protein levels of Wnt1, β-catenin, GSK3β, and Cyclin D1 in each group. Data are presented as mean ± SD ( n = 3 independent biological replicates). * p < 0.05, *** p < 0.001 vs. the PBS group, ### p < 0.001 vs. the BMSCs-Exo + NC inhibitor group.
Article Snippet: Human bone mesenchymal stem cells (BMSCs) obtained from Procell Biotechnology Co. LTD (Wuhan, China) were cultured in commercial BMSCs complete medium (Procell) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin at 37 °C and 5% CO 2 .
Techniques: Inhibition, Derivative Assay, Expressing, Quantitative RT-PCR, Staining, Western Blot